Tasisulam
Tasisulam - 5mg is backordered and will ship as soon as it is back in stock.
Couldn't load pickup availability
Sign up to be the first to know when this product is in stock
Tasisulam is a anticancer agent and induces apoptosis via the intrinsic pathway, resulting in cytochrome c release and caspase-dependent cell death. Tasisulam inhibits mitotic progression and induces vascular normalization.
| Product Name | Tasisulam |
| Synonyms | |
| CAS Number | 519055-62-0 |
| Related CAS | |
| Molecular Formula | C11H6BrCl2NO3S2 |
| Molecular Weight | 415.1 |
| SMILES | ClC1=CC(Cl)=C(C=C1)C(=O)NS(=O)(=O)C1=CC=C(Br)S1 |
| Purity (HPLC) | >= 95% |
| Physical Appearance | White solid |
| Solubility | DMSO, DMF |
| Shipping Conditions | Room Temperature |
| Storage Conditions | Refrigerated |
| Shelf Life | 12 months after the date of delivery |
| Regulatory Statement | For Research Use Only |
References
Li, H., Dong, J., Cai, M., Xu, Z., Cheng, X.-D.,Qin, J.-J., Protein degradation technology: a strategic paradigm shift in drug discovery. Journal of Hematology & Oncology 2021, 14, 138.Xu, Y., Nijhuis, A.,Keun, H. C., RNA-binding motif protein 39 (RBM39): An emerging cancer target. British Journal of Pharmacology n/a.
Documents
Datasheet COA MSDS
Citations
If you know of a paper that uses this product from Tenova Pharma, please let us know.
